Article Versions Notes

Sanduzzi Zamparelli S, Capitelli L, Coppola N, Venditto C, Santoro C, Annunziata G, Bruzzese D, Cuomo N, Gentile I, Bocchino M, et al. A Phase II Study on the Effect of Taurisolo^® Administered via AEROsol in Hospitalized Patients with Mild to Moderate COVID-19 Pneumonia: The TAEROVID-19 Study. Cells. 2022; 11(9):1499. https://doi.org/10.3390/cells11091499

Sanduzzi Zamparelli, Stefano, Ludovica Capitelli, Nicola Coppola, Claudia Venditto, Ciro Santoro, Giuseppe Annunziata, Dario Bruzzese, Nunzia Cuomo, Ivan Gentile, Marialuisa Bocchino, and et al. 2022. "A Phase II Study on the Effect of Taurisolo^® Administered via AEROsol in Hospitalized Patients with Mild to Moderate COVID-19 Pneumonia: The TAEROVID-19 Study" Cells 11, no. 9: 1499. https://doi.org/10.3390/cells11091499

Sanduzzi Zamparelli, S., Capitelli, L., Coppola, N., Venditto, C., Santoro, C., Annunziata, G., Bruzzese, D., Cuomo, N., Gentile, I., Bocchino, M., & Sanduzzi Zamparelli, A. (2022). A Phase II Study on the Effect of Taurisolo^® Administered via AEROsol in Hospitalized Patients with Mild to Moderate COVID-19 Pneumonia: The TAEROVID-19 Study. Cells, 11(9), 1499. https://doi.org/10.3390/cells11091499